Direct accesses

  • Go to main menu
  • Go to main content
Menu
GenSight GenSight
Search the site
  • Contact
  • Careers
  • You are viewing the website in English en
  • fr
Search the site
  • Whowe are
    • Company
    • Leadership
    • Collaborations
  • Our products& pipeline
    • Diseases we target
    • GS010 for LHON
    • GS030 for Retinitis Pigmentosa
    • GS030 for Geographic Atrophy in Dry-AMD
  • Ourtechnologies
    • Technologies we are applying
    • Gene Therapy
    • Mitochondrial Targeting Sequence (MTS)
    • Optogenetics
  • Investors& media
    • Company Overview
    • Press releases
    • Events & presentations
    • News and press coverage
    • Stock information
    • Governance
    • Documentation

Documentation

  • Home >
  • Investors & media >
  • Documentation
08 April 2021
General meetings

Auditors’ report on resolution number 23 Open in new window

08 April 2021
General meetings

Auditors’ report on resolution number 22 Open in new window

08 April 2021
General meetings

Auditors’ report on resolution number 17 Open in new window

08 April 2021
General meetings

Nominees to the Board of Directors – 2021 General Meeting Open in new window

08 April 2021
General meetings

Shares and voting rights statement – 2021 General Meeting Open in new window

08 April 2021
General meetings

Proxy card – 2021 General Meeting Open in new window

08 April 2021
General meetings

Notice of General Meeting on April 29, 2021 Open in new window

08 April 2021
General meetings

BALO prior notification – 2021 General Meeting Open in new window

08 April 2021
Financial statements and reports, General meetings

2020 Universal Registration Document Open in new window

22 October 2020
Regulated information

Securities Note Open in new window

  • View previous 9 articles
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 13
  • View next 9 articles
© 2022 Gensight Biologics
  • Terms of use
  • Sitemap
  • Contact
  • Credits
  • Cookies management
Go back to the page of the page